drugset / Trial / NCT03030430
Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to establish PK similarity in the treatment of BAT1706 and comparators.
Timeline
- Start
- 2016-03-15
- Primary completion
- 2017-05-16
- Completion
- 2017-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAT1706 | Unknown | 1 mg/kg | Intravenous |
| Comparator | Bevacizumab | Monoclonal antibody | 1 mg/kg | Intravenous |